Spese Operative Cambiamento Data
Acadia Pharmaceuticals USD 270.57M 450K 2026-09
ALKERMES USD 1.86B 56.17M 2026-09
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
Biogen USD 2.32B 663.6M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Cara Therapeutics USD 7.05M 1.11M 2026-03
Corcept Therapeutics USD 225.75M 10.9M 2026-09
Cytokinetics USD 214.64M 6.85M 2026-09
Eisai JPY 218.93B 9.33B 2026-09
Eli Lilly USD 10.52B 496M 2026-06
Incyte USD 5.64B 4.67B 2026-09
J&J USD 18.93B 1.09B 2026-09
Moderna USD 1.18B 223M 2026-09
Neurocrine Biosciences USD 779.7M 40.6M 2026-09
Pfizer USD 89B 3.81B 2026-09
Prothena USD 19.7M 5.6M 2026-06
PTC Therapeutics USD 211.54M 15.12M 2026-06
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Ultragenyx Pharmaceutical USD 283M 6M 2026-09
Vanda Pharmaceuticals USD -1.14B 1.6B 2025-12
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09